Related by context. All words. (Click for frequent words.) 67 Troxatyl 67 molecular imaging radiopharmaceutical 67 targeted radiotherapeutic 66 polysaccharide polymer 66 candidate REP# 66 M# rationally 66 ALTROPANE R 66 Personalized Immunotherapy 66 Zemiva TM 65 PANVAC VF 65 TOCOSOL 65 romidepsin novel 65 Initiate Clinical Trial 65 candidate deforolimus 65 GVAX R 65 DPX Survivac 64 compound perifosine 64 CB2 selective receptor agonist 64 3 registrational trial 64 Annamycin 64 pafuramidine maleate 64 ONCONASE R 64 Azedra TM 64 TELINTRA R 64 PNP inhibitor 63 GVAX ® 63 Dendreon investigational 63 Phase IIb clinical trials 63 mitogen activated ERK kinase 63 Solazed 63 Factor VIIa 63 Initiates Enrollment 63 commercialize deforolimus ARIAD 63 candidate TNFerade biologic 63 TNFerade ™ 63 Unit Dose Budesonide 63 non nucleoside inhibitor 63 Allovectin 7 63 ALN PCS 63 sterile lidocaine patch 63 AAG geldanamycin analog 63 PLK1 SNALP 63 Trofex TM 63 Cloretazine ® 63 OvaRex R 62 CYT# vascular disrupting 62 Panzem R 62 Initiates Clinical Trial 62 Completes Patient Enrollment 62 SinuNase ™ 62 ASONEP TM 62 BiovaxID TM 62 Iluvien ® 62 ASONEP ™ 62 overactive bladder AA# 62 PF # [002] 62 Solazed TM 62 Files IND 62 initiated Phase Ib 62 Archexin 62 Angiocept 62 lintuzumab SGN 62 Davanat 62 Begins Dosing 62 Initiates Phase II 62 developing Zerenex ferric 62 Kosan dependence 62 acetonide FA 62 Auxilium transmucosal film 62 delivers fluocinolone acetonide FA 62 Fx #A 62 Empatic TM 62 TOCOSOL Camptothecin 62 anti botulism antibody 62 compound INCB# 62 Panzem ® 62 TNFerade TM 62 Initiates Phase III 62 DCVax R 62 Achieves Primary Endpoint 62 Kamada AAT 62 IL# PE#QQR 62 Panzem R NCD 62 concerning CombinatoRx 61 forodesine 61 non porcine pancreatic 61 paclitaxel Taxol ® 61 include Phenoptin TM 61 Alfacell proprietary ribonuclease 61 HuMax TAC 61 ZEVALIN ® 61 Exherin 61 oral prodrug 61 Cotara ® 61 Neo Kidney Augment 61 histamine dihydrochloride 61 Phase #b/#a clinical 61 topically applied SEPA 61 sores onychomycosis nail 61 Initiates Clinical 61 PEG irinotecan 61 including eniluracil ADH 61 Xcytrin R 61 Generx ™ 61 IMA# 61 intranasal formulation 61 OvaRex 61 SinuNase TM 61 metastatic carcinoid 61 Receives Orphan Drug Designation 61 NASH Huntington 61 oncolytic virus therapies 61 Sphingomab TM 61 bladder ovarian 61 Onalta ™ 61 candidate ridaforolimus 61 oral beclomethasone dipropionate 61 Initiates Phase 2b 61 Acetavance TM intravenous acetaminophen 61 novel L DOS# 61 SPRYCEL ® 61 Pafuramidine 61 ILUVIEN ® 61 progressive metastatic prostate 61 oral ridaforolimus 61 Tramiprosate ALZHEMED TM 61 sapacitabine CYC# 61 tosedostat 61 dermatology biopharmaceutical company 61 Trofex 61 2 methoxyestradiol 61 VALSTAR TM 60 HDL Selective Delipidation 60 Aflibercept 60 VitiGam TM 60 SCIB1 60 anticancer compound 60 therapeutic monoclonal antibody 60 Breast Cancer Assay 60 Granted Orphan Drug 60 Soliris TM eculizumab 60 Myocet 60 pipeline GlycoPEG GCSF 60 RSR# 60 Intravenous CP 60 virus HCV protease inhibitor 60 targeted antifolate 60 PORxin TM 60 IMPDH inhibitor 60 investigational oral hepatitis C 60 Aganocide 60 GW# [003] 60 treat chronic sinusitis 60 Tocosol Paclitaxel 60 generation PNP inhibitor 60 Alzhemed TM 60 Memryte 60 Phase 2b Clinical Trial 60 Cardio Vascu Grow 60 targets Galectin receptors 60 Zybrestat 60 CMV vaccine 60 PDE4 inhibitor 60 Bayer Onyx 60 inhaled liposomal ciprofloxacin 60 aldehyde dehydrogenase ALDH2 deficiency 60 RhuDex ® 60 selective estrogen receptor modulator 60 OvaRex ® MAb 60 Civacir 60 Investigational Oral 60 R sorafenib tablets 60 Evoltra ® 60 THR beta agonist 60 essential thrombocythemia ET 60 Meets Primary Endpoint 60 Difimicin 60 treat nephropathic cystinosis 60 Panzem 60 NeoLipid R 60 intravenous recombinant 60 EVIZON TM squalamine lactate 60 intranasal insulin product 60 Therapeutic Vaccine 60 Empatic ™ 60 apricitabine ATC 60 Perflubutane Polymer Microspheres 60 Anturol ® 60 HDL Mimetic Peptide 60 proprietary HuCNS SC 60 personalized immunotherapy 60 Cannabinor 60 novel therapeutic antibodies 60 RNAi Therapeutic 60 Panzem NCD 60 personalized dendritic 60 BrachySil TM 60 alvespimycin 59 drug GAP #B# 59 trial evaluating PRX# 59 valtorcitabine 59 PDX pralatrexate 59 orally inhaled migraine 59 SMT C# 59 thrombin component 59 Submits NDA 59 PEGylated Fab fragment 59 Pegloticase 59 ARRY # 59 novel oral anticoagulant 59 Temsirolimus 59 AFREZZA ® 59 histone deacetylase HDAC inhibitor 59 Kuvan TM sapropterin 59 recurrent metastatic 59 polycythemia vera essential thrombocythemia 59 accumulate preferentially 59 sapropterin dihydrochloride Phase 59 iSONEP ™ 59 Hedgehog antagonist 59 ACAPODENE TM 59 XL# XL# 59 MyVax ® 59 XL# anticancer compounds 59 metaglidasen 59 Tykerb lapatinib 59 Prednisone Against Refractory 59 Submits Biologics License Application 59 hypoxia activated prodrug 59 Albugon 59 BRAF mutant 59 RhuDex TM 59 MAb therapy 59 Presents Preclinical Data 59 drug NP2 Enkephalin 59 Vitrasert R 59 LymphoStat B TM 59 Genasense ® oblimersen 59 Immunotherapeutic 59 candidate XP# 59 CEQ# 59 Velcade bortezomib 59 omacetaxine mepesuccinate 59 candidate epratuzumab 59 Hedgehog Pathway Inhibitor 59 seliciclib CYC# 59 IgG1 monoclonal antibody 59 TLR9 agonist IMO 59 Cintredekin Besudotox 59 Licenses Novel 59 orally administered inhibitor 59 ficlatuzumab 59 EVIZON ™ 59 Peginterferon alfa 2b 59 Amgen Neulasta ® 59 relapsed leukemia 59 immunotherapeutic vaccine 59 vinorelbine tartrate 59 TRO# 59 oxybutynin ATD TM 59 Amgen Neulasta R 59 mertansine 59 Arzerra ofatumumab 59 generation purine nucleoside 59 IRX 2 59 hematological indications 59 telomerase therapeutic 59 lead molecular radiotherapeutic 59 nephropathic cystinosis 59 Aurora Kinase 59 AQ4N 59 Hsp# Inhibitor 59 Proxinium TM 59 Octreotide 59 Injectable Suspension 59 ELACYT 59 compound ISA# 59 intravenous acetaminophen 59 IMiDs R 59 oral methylnaltrexone 58 Fibrin Pad 58 immunosuppressant therapies 58 isoform selective 58 SYN# 58 dutogliptin 58 RNAi therapeutic targeting 58 tiapamil 58 dasatinib Sprycel ® 58 paclitaxel Taxol R 58 Reports Preclinical Data 58 Presents Preclinical 58 Vascular Disrupting Agent 58 taxane chemotherapy administered 58 muscarinic receptor agonist 58 CA9 SCAN 58 antibody MAb 58 Ixempra 58 IND submission 58 PrevOnco 58 Vertex hepatitis C 58 faropenem medoxomil 58 Omigard 58 MCSP respectively 58 Announces Poster Presentations 58 follicular Non Hodgkin 58 liposomal formulation 58 EGS# 58 XP# XP# 58 Intermezzo ® zolpidem tartrate 58 investigational pharmacologically unique 58 Xeloda ® 58 JAK2 Inhibitor 58 Successfully Completes Phase 58 DURIN TM 58 TBC# 58 Familial Adenomatous Polyposis FAP 58 investigational hepatitis C 58 Cx# [002] 58 iSONEP TM 58 Submits IND 58 modified glutathione analog 58 Marqibo TM 58 Qutenza TM 58 EndoTAGTM 1 58 alemtuzumab Campath 58 drug Treanda 58 Spiegelmer ® 58 Onconase 58 telomerase inhibitor drug 58 metastatic renal cell 58 sunitinib Sutent 58 Provectus Pharmaceuticals specializes 58 PI3K/Akt pathway inhibitor 58 oral picoplatin 58 DCVax ® Brain 58 anti infective treatments 58 metastatic colorectal 58 VitiGam 58 BEMA Granisetron 58 Campath ® 58 drug figitumumab 58 investigational humanized monoclonal antibody 58 Nektar proprietary 58 Arimidex anastrozole 58 Guanilib 58 midstage clinical 58 Generx TM 58 Zemiva ™ 58 Patients Treated With 58 HepeX B 58 LymphoStat B belimumab 58 acyclovir Lauriad R 58 systemic anaplastic large 58 injectable investigational 58 HQK 58 Temodar ® 58 novel emulsion formulation 58 XYOTAX TM 58 torezolid phosphate 58 IV APAP 58 Bezielle 58 radiation sensitizer 58 Anavex #-# 58 L BLP# 58 gastro intestinal inflammation 58 Alzheimer disease cognitive dysfunction 57 DAVANAT ® 57 HyperAcute 57 vinca alkaloid 57 trastuzumab DM1 T DM1 57 rxRNA 57 oral anti arrhythmic 57 adalimumab Humira 57 Augment ™ 57 IMiDs ® 57 Mepact 57 Zavesca r 57 Amrubicin 57 Nexavar sorafenib 57 ZOLINZA 57 LSE ASM 57 Submits Response 57 pharmacogenomic translational research 57 HDAC Inhibitor 57 ® bortezomib 57 treats acute lymphoblastic 57 Inhibiting Nitric Oxide Donating 57 Nasdaq ACHN 57 OTCBB CVBT 57 aurora kinase 57 Somatuline Depot 57 Forodesine 57 oral salmon calcitonin 57 rhIGF-I/rhIGFBP-3 57 NU# direct 57 BLP# Liposome Vaccine 57 Romidepsin 57 OTCQB CTIX 57 selective immunoproteasome inhibitor 57 PTK# 57 Exherin TM 57 Zenapax 57 Augment TM 57 refractory chronic lymphocytic 57 MyVax R 57 psoriasis rheumatoid arthritis 57 MKC# MT 57 prophylactic vaccine 57 MAGE A3 ASCI 57 topical anti infective 57 Chemokine Therapeutics 57 pan histone deacetylase 57 dasatinib Sprycel 57 AN# novel 57 Drug Candidate 57 GlaxoSmithKline Tykerb 57 ZK EPO 57 OMP #R# 57 docetaxel Taxotere ® 57 candidate AP# 57 approved incretin mimetic 57 proprietary intranasal insulin 57 Onyx Pharmaceuticals Announces 57 CR# vcMMAE 57 ZYBRESTAT TM 57 small molecule tyrosine 57 Safinamide 57 Actimmune ® 57 Bosutinib 57 Onalta 57 Matrix Phase 2b 57 chemosensitizer 57 ATG Fresenius S 57 ruxolitinib 57 Syncria R 57 Anticancer Drug 57 Shows Statistically Significant 57 candidate Zemiva TM 57 small molecule Hedgehog 57 Erbitux cetuximab 57 Canvaxin TM 57 proprietary intravenous formulation 57 Opterone R 57 Corixa Corporation 57 TLK# 57 PEG SN# 57 thalidomide Thalomid 57 glucokinase activator 57 IAP inhibitors 57 Vectibix panitumumab 57 Iluvien TM 57 ocular formulation 57 semi synthetic lipoglycopeptide 57 systemic RNAi therapeutic 57 FUSILEV enhances 57 AMPA kainate 57 Intravenous Human 57 tubulin inhibitor 57 Inc. Nasdaq IMGN 57 DOS# 57 metastatic sarcomas 57 Onco TCS 57 Aganocide ® 57 PROVENGE sipuleucel T 57 AdhTAP 57 Simulect 57 multi kinase inhibitor 57 negative allosteric modulator 57 Camptosar ® irinotecan 57 delivery polymer matrix 57 Kuvan R 57 TransVax 57 Maribavir 57 product candidate Lpathomab 57 Novel Oral 57 Pruvel 57 oropharyngeal candidiasis OPC 57 FOLOTYN ® 57 tezampanel NGX# 57 novel histone deacetylase 57 OVATURE 57 Investigational Treatment 57 beta 1a 57 Collategene 57 Steven R. Deitcher 57 ionotropic glutamate receptor antagonists 57 cathepsin K inhibitor 57 tamoxifen citrate 57 YONDELIS 57 volociximab 57 bucindolol hydrochloride 57 sorafenib tablets 57 candidates Azedra TM 57 ® natalizumab 56 Ascend Therapeutics 56 Bayer Nexavar 56 Tumour Vascular Disrupting Agent 56 Crofelemer budesonide foam 56 Maxy G# 56 NASDAQ OMER 56 Manja Bouman CEO 56 thetreatment 56 inhaled AAT 56 developing ostarine selective 56 EP #R 56 SNS# T 56 HepaSphere 56 docetaxel Taxotere R 56 anti CD3 monoclonal 56 drug ISA# 56 Cetrorelix 56 MKC# MKC# PP 56 PNT# 56 Canvaxin 56 MyVax personalized immunotherapy 56 QNEXA ® 56 MAXY VII 56 Nanobody 56 SILENOR TM doxepin HCl 56 Elagolix 56 oral nucleoside analogue 56 refractory colorectal cancer 56 KRN# 56 SUTENT ® 56 advanced carcinoid 56 apomorphine hydrochloride 56 lexidronam injection 56 Urocidin TM 56 R sipuleucel T 56 Kinase Inhibitor 56 radiation enteritis 56 hormone refractory metastatic prostate 56 TKM PLK1 56 Tezampanel 56 IV Busulfex 56 receptor tyrosine kinase inhibitor 56 IMiD 56 Tocosol 56 Alimta pemetrexed 56 relapsed acute lymphoblastic 56 CINTREDEKIN BESUDOTOX 56 ORE# 56 FluCide 56 drug tesmilifene 56 S1P antibody 56 phase IIb trial 56 rALLy clinical trial 56 5 FU leucovorin 56 CAMPATH 56 LEP ETU 56 CYT# potent vascular disrupting 56 IMC #B 56 Androxal TM 56 BZL# 56 Orally administered 56 Vicriviroc 56 novel immunotherapies 56 Fibrillex TM 56 cell carcinoma RCC 56 IAP inhibitor 56 Inc. Nasdaq ALNY 56 hyaluronidase enzyme 56 Bioral ® 56 Idera Pharmaceuticals develops 56 Cimzia TM 56 PROSTASCINT R 56 dextromethorphan quinidine 56 successfully commercialize Iluvien 56 Xyfid TM 56 Optiquel ™ 56 CINOD 56 Oracea TM 56 Cand5 56 Neuvenge 56 immunotherapeutic approaches 56 Selective Electrochemical Tumor Ablation 56 agonistic human 56 triggers apoptosis programmed 56 selective S#P# receptor agonist 56 Phase III ADT 56 INTEGRILIN R eptifibatide Injection 56 INxin 56 Bazedoxifene 56 IMC #F# 56 AMEX RGN 56 PrevOnco ™ 56 Initiate Phase 56 Occlusin TM 56 Oral NKTR 56 lupus renal disease 56 ATL# [002] 56 ALN TTR 56 methylnaltrexone bromide 56 EndoTAG 56 anti PlGF 56 Insegia 56 tramiprosate Alzhemed TM 56 Bafetinib 56 Diabetic Macular Edema DME 56 compound COTI 56 metastatic pancreatic 56 Talabostat 56 evaluating T DM1 56 Investigational Compound 56 estrogen receptor beta agonist 56 vinflunine 56 Prodarsan R 56 BrachySil ™ 56 ALVESCO R 56 candidates Azedra 56 humanised monoclonal antibody 56 Therapeutic Competitors companiesandmarkets.com adEgemonye 56 active cellular immunotherapy 56 opioid induced bowel dysfunction 56 Ceflatonin R 56 pralatrexate injection folate analogue 56 oral proteasome inhibitor 56 atacicept 56 candidate iSONEP TM 56 Solazed ™ 56 BRAF inhibitor 56 LibiGel ® 56 vapreotide acetate 56 using VIAdel TM 56 EcoNail TM 56 Ozarelix 56 Theratope 56 adenosine A2A 56 vaccine GMK 56 HyACT 56 CRD5 56 radiotherapeutic 56 kidney urologic 56 CD# antibody [002] 56 iii GTx 56 JAK1 56 Inhalation Solution 56 VEGFR2 inhibitor 55 humanized therapeutic 55 carbohydrate polymer 55 efaproxiral 55 Pimavanserin 55 TRIOLEX HE# APOPTONE HE# 55 Nexavar sorafenib tablets 55 PSMA ADC 55 commercialize deforolimus 55 Spiegelmer 55 evaluating tivozanib 55 Gemzar gemcitabine 55 ALVESCO ® 55 Daclizumab 55 Novolimus 55 inhibit metastasis 55 engineered anticoagulant 55 Veronate R 55 RhuDex 55 Asentar 55 drug GLPG# 55 TRAIL receptor antibodies 55 phase IIb clinical 55 romazarit 55 PDE# inhibitors 55 reslizumab 55 delivers sumatriptan 55 CTAP# Capsules 55 clinical trials Archexin 55 Squalamine 55 Behcet uveitis 55 developer Antisoma plc 55 Phase 2b Trial 55 Cethrin R 55 hoFH 55 KSP inhibitor 55 HuMax 55 sitaxsentan 55 toenail onychomycosis 55 otelixizumab 55 TELINTRA 55 gastrointestinal mucositis 55 OMP #M# 55 Clavis Pharma 55 pan HDAC inhibitor 55 tolevamer 55 CORT # estimates 55 Excellarate TM 55 proprietary radiolabeled monoclonal 55 incyclinide 55 Cloretazine 55 Silodosin 55 Liprotamase 55 Metastatic Melanoma 55 RNA antagonists 55 INCB# [001] 55 EVIZON TM 55 hereditary emphysema 55 SonoLysis 55 albiglutide 55 metastatic colorectal carcinoma 55 immunomodulatory therapy 55 JAK2 inhibitor 55 selective angiogenic kinase inhibitor 55 Degarelix 55 investigational integrase inhibitor 55 PEGylated interferon 55 cetuximab Erbitux 55 Pfizer Camptosar 55 Targretin capsules 55 Cerimon 55 rindopepimut 55 Chronic Myeloid Leukemia CML 55 huC# DM4 55 Aviptadil 55 specific lectin receptors 55 neuropathic pain spasticity 55 class mGluR5 inhibitor 55 castration resistant hormone refractory 55 Omacetaxine 55 novel VDA molecule 55 demonstrated antitumor activity 55 Inhalation Aerosol 55 5 fluorouracil leucovorin 55 INS# [001] 55 Laquinimod 55 doublet chemotherapy 55 Daniel Junius 55 Tesmilifene 55 neoadjuvant setting 55 PresbyLens ® 55 metastatic bladder 55 Phase #/#a trial 55 GEM OS2 55 OncoVex 55 XmAb ™ 55 TKM ApoB 55 Omthera 55 Systemic Delivery 55 topical gel containing 55 NV1FGF 55 R#/MEM # 55 Transdermal Patch 55 brivaracetam 55 DepoCyt 55 Luveris 55 antibody MT# 55 Completes Enrollment 55 cetuximab Erbitux R 55 Tyzeka Sebivo 55 vigabatrin GABA aminotransferase inhibitor 55 macitentan 55 sorafenib Nexavar 55 potent suppressor 55 Roche Herceptin 55 vidofludimus 55 OMNARIS HFA 55 oral talactoferrin 55 eniluracil 55 vi Immtech ability 55 novel peptide 55 Sphingomab 55 Romiplostim 55 BRIM2 55 Anidulafungin 55 Vidaza azacitidine 55 Advaxis Phase 55 Nasulin ™ 55 infectious diseases autoimmune diseases 55 Adrian Hobden Ph.D. 55 ThermoDox R 55 investigational therapies 55 R lenalidomide 55 octreotide implant 55 Raptiva R 55 taxane refractory 55 Phase Ib II 55 Initiates Dosing 55 diabetes irritable bowel 55 commercialize CorMedix drug 55 CCR9 antagonist 55 Pathway Inhibitor 55 metastatic HER2 negative 55 Stimuvax R 55 Nanobody R 55 inhalation powder 55 AFREZZA TM 55 cannabinor 55 INTEGRILIN ® 55 pain palliation 55 Gleevec Glivec 55 Elisabeth Lindner CEO 55 Muraglitazar 55 sodium Injection 55 KIACTA ™ 55 Harry Palmin President 55 GED aPC 55 ospemifene 55 BCG refractory carcinoma 55 Pivotal Phase III 55 Inc. NASDAQ ORXE 55 Begins Clinical Trial 55 alkylating agent 55 JAK inhibitor 55 Delafloxacin 55 lucinactant 55 Curaxin CBLC# 55 Capesaris 55 Triapine 54 topical antifungal 54 brivanib 54 LBH# 54 FOLFOX6 chemotherapy regimen 54 Myelodysplastic Syndrome MDS 54 inhaled antibiotic 54 Neupogen ® 54 Omigard TM 54 AzaSite Plus 54 metastatic malignant 54 HGS ETR2 54 neuropathic pain metabolic diseases 54 Perforomist TM formoterol fumarate 54 StemEx R 54 YONDELIS R 54 assessing T DM1 54 Trovax 54 depsipeptide 54 pioglitazone hydrochloride 54 Sprycel dasatinib 54 treat secondary hyperparathyroidism 54 OSI Tarceva 54 deCODE ProstateCancer TM 54 rifalazil 54 EOquin TM 54 2A receptor agonist 54 HuCNS SC ® 54 Tarvacin Anti Cancer 54 Bayer HealthCare Onyx Pharmaceuticals 54 rALLy 54 Antiangiogenic 54 selective kinase inhibitor 54 TroVax ® 54 AERx ® 54 Atiprimod 54 Aceon 54 optimal dosing regimens 54 phase III isavuconazole 54 please visit http:/www.sunesis.com 54 topical gel formulation 54 HSP# inhibitor 54 Sudhir Agrawal D.Phil 54 Aryplase 54 nanopharmaceutical 54 Zorbtive TM 54 Parathyroid Hormone 54 Mipomersen 54 next generation URAT1 54 multiple myeloma MM 54 non resectable metastatic 54 Interferon beta 54 Epeius Biotechnologies Corporation 54 GRN# 54 PROSTVAC VF 54 non resectable 54 Cloretazine R 54 hypoxia selective 54 adecatumumab MT# 54 NeuroSTAT ® 54 5 HT2C serotonin 54 LungAlert TM 54 itraconazole Sporanox 54 Deforolimus 54 Neutrolin 54 Azmacort R 54 Varespladib 54 cetuximab Erbitux ® 54 RTP #i 54 COPREXA ™ 54 dexanabinol 54 brand ciclesonide HFA 54 XSSE OXGN 54 Phase lll 54 AGGRASTAT R Injection tirofiban 54 EZN 54 cancer immunotherapies 54 Factor Xa inhibitor 54 Lixivaptan 54 Akt inhibitor 54 imatinib Gleevec ® 54 markets COLAZAL 54 gets USFDA nod 54 candidate Zemiva 54 neuro inflammatory 54 nalbuphine ER 54 Ostabolin C TM 54 Renal Cell Carcinoma RCC 54 fosbretabulin 54 angiogenesis inhibitor 54 CCR5 mAb 54 ATL# [001] 54 Oral Spray 54 cell lymphoma CTCL 54 microtubule inhibitor 54 Phase 2a Clinical Trial 54 INSPIRE Trial Phase III 54 Idiopathic Pulmonary Fibrosis 54 Thiarabine 54 Corlux 54 Curaxin 54 initiate Phase IIa 54 ALN TTR# 54 Potelligent Technology 54 Novosom 54 Posaconazole 54 IG HCR ;) CO 54 RenaZorb TM 54 Phase 1b clinical trials 54 metastatic renal 54 ASCO GI 54 lapatinib Tykerb 54 oral dihydropyrimidine dehydrogenase DPD 54 Trodusquemine MSI 54 ATRA IV 54 Posiphen TM 54 R Bortezomib 54 HP Acthar R 54 topically administered 54 previously untreated follicular 54 mild vasodilator 54 pancreatic colon 54 skeletal sarcomere activator 54 oxypurinol 54 AEG# 54 Biological Therapy 54 Solzira ™ 54 aerosolized AAT 54 oral ghrelin agonist 54 Certolizumab pegol 54 refractory gout 54 monoclonal antibody conjugated 54 orally disintegrating 54 Fibrillex 54 midstage clinical trials 54 RECOTHROM R 54 factor VIIa 54 NASDAQ INGN 54 ALK inhibitor 54 smoldering multiple myeloma 54 CONBRIZA 54 ophthalmology dermatology cardiovascular disease 54 please visit http:/www.avastin.com 54 Torisel temsirolimus 54 metastatic gastric 54 Vidaza R 54 Pyridorin 54 PEG uricase 54 FDA Okays 54 induced macular edema 54 Hodgkin lymphoma HL 54 gefitinib Iressa 54 chimeric monoclonal antibody 54 Bonefos 54 AQD class 54 Nasdaq SNSS 54 tumors GIST 54 IIb clinical trial 54 JAK#/JAK# inhibitor CYT# 54 carcinoid syndrome diabetes 54 sirtuin inhibitor program 54 p# inhibitor 54 Liposomal Grb 2 54 fibrotic disorders 54 epothilones 53 candidate DB# 53 phase IIa clinical 53 non nucleoside HCV 53 Dasatinib 53 Bevasiranib 53 regorafenib 53 RELOVAIR ™ 53 indolent follicular non 53 NEUGENE R 53 infectious diseases autoimmune 53 Eculizumab 53 indibulin 53 SNT-MC#/idebenone 53 Anti Tumor 53 antimitotic 53 TG# [003] 53 Zarnestra 53 include ColorectAlert TM 53 lung pancreatic 53 interferon alpha IFN 53 cellular immunotherapy 53 trastuzumab DM1 53 Epratuzumab 53 Horizant ™ 53 ALN VSP Phase 53 candidate Liposomal Grb 53 NASDAQ CXSP announced 53 lumiliximab 53 Angiogenesis